Bulletin
Investor Alert

June 16, 2021, 11:52 a.m. EDT

Metastatic Breast Cancer Treatment Market to Grow with a Moderate CAGR During 2021-2029; Increasing Prevalence of Cancer to Drive the Market Growth

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

Jun 16, 2021 (AmericaNewsHour) -- Research Nester released a report titled "Metastatic Breast Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029" which delivers detailed overview of the global metastatic breast cancer treatment market in terms of market segmentation by treatment type, end-user and region.

Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with the growth of the market.

The  metastatic breast cancer treatment market  is projected to grow with a high CAGR during the forecast period, i.e., 2021-2029 on account of the increasing elderly population and the rising prevalence of breast cancer. According to Globocan report 2020, the incidence rate of breast cancer was 5.20% which accounted for 2.26 million new cases globally with a mortality rate of 6.9%.

The market is segmented by treatment type into chemotherapy, radiation therapy, biologic, targeted therapy, breast surgery, and hormone therapy. Among these segments, the chemotherapy and radiation therapy is anticipated to hold the largest share by the end of 2021 in the metastatic breast cancer treatment market as a result of the lesser side-effects and high specificity rate.

Download Sample of This Strategic Report:  https://www.researchnester.com/sample-request-2998

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, out of which, the metastatic breast cancer treatment market in the Asia Pacific is projected to grow at the highest CAGR throughout the forecast period. Currently, the market in North America holds the largest share. This can be attributed to the presence of leading healthcare providers in the region, especially in the United States, who are extensively involved in the research and development for innovative metastatic breast cancer treatment.

Increasing Ageing Population and Breast Cancer Prevalence to Drive Market Growth

According to the United Nations, it is estimated that by 2050, every one in six people will be 65 years or older, i.e., 16% of the total world population. Along with this, the number of persons above 80 years or older is also projected to triple by the end of 2050.

"The Final Report will cover the impact analysis of COVID-19 on this industry."

Download/Request Sample Copy of Strategic Report:   https://www.researchnester.com/sample-request-2998

Increasing demand for metastatic breast cancer treatments has increased with the growing ageing population and the rise of new advanced technologies are some of the major factors that drive the growth of the global market. However, the high risk associated with the radiation exposure along with lack of awareness are some of the factors that are estimated to restrain market growth in the near future.

This report also provides the existing competitive scenario of some of the key players of the global metastatic breast cancer treatment market which includes company profiling of F. Hoffmann-La Roche Ltd, Merck & Company, Inc., AstraZeneca Plc., Novartis, Amgen Inc., Pfizer Inc., Eli Lilly and Company, Sun Pharmaceutical Industries Limited, Johnson & Johnson, GlaxoSmithKline plc., and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global metastatic breast cancer treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

About Research Nester

Research Nester is a one-stop service provider with a client base in more than 50 countries, leading in strategic market research and consulting with an unbiased and unparalleled approach towards helping global industrial players, conglomerates and executives for their future investment while avoiding forthcoming uncertainties. With an out-of-the-box mindset to produce statistical and analytical market research reports, we provide strategic consulting so that our clients can make wise business decisions with clarity while strategizing and planning for their forthcoming needs and succeed in achieving their future endeavors. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds.

Contact for more Info:

AJ Daniel

Email:  info@researchnester.com

U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

The post Metastatic Breast Cancer Treatment Market to Grow with a Moderate CAGR During 2021-2029; Increasing Prevalence of Cancer to Drive the Market Growth appeared first on America News Hour .

COMTEX_388380032/2606/2021-06-16T11:51:40

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.